Purchase Order HHSN268201700015A

The NIH Clinical Center awarded a $23,613.01 firm fixed-price purchase order to Lonza Walkersville, Inc. for procurement of a 4D-Nucleofector System. The contract, awarded on September 3, 2025, with completion targeted for September 2, 2026, represents an open competition award with no set-aside designation. Lonza Walkersville, a foreign-owned biological materials and laboratory equipment manufacturer based in Walkersville, Maryland, will perform the work at its local facility. The...

The Food and Drug Administration awarded a firm fixed price purchase order to Lonza Walkersville, Inc. for the purchase of a 4D Nucleofector instrument and accessories, with a contract ceiling value of $59,695.40. The solicitation was posted on August 19, 2019, with a due date of August 26, 2019, and the contract was awarded on August 29, 2019, with an ultimate completion date of September 3, 2024. This procurement was conducted as open competition with no set-aside designation. The work will be...

<p>The National Heart Lung and Blood Institute awarded a purchase order to Life Technologies Corporation for maintenance services valued at $10,125.40 on July 6, 2017, with an ultimate completion date of July 5, 2018. Performance is located in Bethesda, Maryland. The order covers firm fixed price maintenance support for scientific equipment. No set-aside was applied.</p>

This delivery order, awarded to Lonza Walkersville, Inc. on September 18, 2012, carries a ceiling value of $713,046 and represents a firm fixed-price contract with the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health. The contract, which operated through September 16, 2017, was awarded without a set-aside designation, indicating open competition. Performance of work occurs at Lonza Walkersville's facility in Walkersville, Maryland. As a...

This is a firm-fixed-price BPA call awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke to Lonza Walkersville, Inc., a for-profit manufacturer, for the provision of a 4D NUCLEOFECTOR CORE UNIT and 4D NUCLEOFECTOR X-UNIT. The work is to be performed at Lonza's Walkersville, Maryland facility. The potential value of this award is $24,220.01 and the completion date is December 31, 2024. This award...

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Lonza Walkersville, Inc., a subsidiary of Lonza Group Ltd. The $36,600 firm fixed-price purchase order is for the delivery of a 4D-Nucleofector X-Unit, a specialized laboratory instrument used for cell transfection research. The contract does not have a set-aside designation. Lonza Walkersville is a leading provider of...

This is a Firm Fixed Price contract awarded by the National Heart Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), to Lonza Walkersville, Inc. for the procurement of an electroporation system. The purpose of this equipment is to facilitate the delivery of biomolecules to cultured cells for the NHLBI Laboratory of Ribonucleoprotein Biochemistry. The contract has a ceiling value of $22,459.01 and a completion date of October 10, 2024. Lonza...

The National Cancer Institute awarded a $18,944 firm fixed price BPA call to Lonza Walkersville, Inc. for a 4D-Nucleofector X Unit. The contract was awarded on September 20, 2022, with an ultimate completion date of September 19, 2023, and will be performed at the awardee's location in Bethesda, Maryland. This procurement was conducted through open competition with no set-aside designation. Lonza Walkersville is a Maryland-based subsidiary of the global Lonza Group specializing in biological...

This is a firm fixed-price purchase order valued at $9,947.51, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Lonza Walkersville, Inc. for Nucleofector laboratory equipment. The contract has a completion date of September 5, 2014 and was awarded on August 27, 2014. Lonza Walkersville is a subsidiary of Lonza Group Ltd., a global life sciences company, and is a leading provider of specialized biological...

This firm fixed-price purchase order was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Lonza Walkersville, Inc., a foreign-owned for-profit manufacturer of laboratory equipment and scientific supplies. The $22,703.01 contract is for the provision of a Lonza 4D Nucleofector transfection instrument and associated component parts to support genome engineering research using CRISPR-Cas9 technology, particularly...